StockNews.com started coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research note issued to investors on Wednesday. The firm issued a hold rating on the stock.
China Pharma Stock Down 11.4 %
Shares of China Pharma stock opened at $0.20 on Wednesday. The company has a quick ratio of 0.24, a current ratio of 0.84 and a debt-to-equity ratio of 0.19. The firm’s 50-day moving average price is $0.23 and its two-hundred day moving average price is $0.25. China Pharma has a 1-year low of $0.17 and a 1-year high of $1.16.
China Pharma (NYSE:CPHI – Get Free Report) last announced its quarterly earnings data on Wednesday, August 14th. The company reported ($0.09) EPS for the quarter. China Pharma had a negative return on equity of 60.19% and a negative net margin of 70.47%. The company had revenue of $0.93 million during the quarter.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Stories
- Five stocks we like better than China Pharma
- Learn Technical Analysis Skills to Master the Stock Market
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- There Are Different Types of Stock To Invest In
- MarketBeat Week in Review – 11/4 – 11/8
- 10 Best Airline Stocks to Buy
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
